Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists

Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts

Sophie GONG, Sr. scientist, GlaxoSmithKline, London, GSK, R&D China

Discovery, structure-activity relationship study and biological evaluation of 2-thioureidothiophene-3-carboxylates as a novel class of C-X-C chemokine receptor 2 (CXCR2) antagonists - ScienceDirect

Development of fluorescent peptide G protein‐coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators - Farmer - 2022 - The FASEB Journal - Wiley Online Library

Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors - ScienceDirect

One-Pot 1,1-Dihydrofluoroalkylation of Amines Using Sulfuryl Fluoride

Kelly Dong's research works China FAW Group Corpration R&D Center, Jilin and other places

Directing the Metabolism of Drugs Away from CYP450: The Use of Oxetane Rings

Ting Yang's research works China Academy of Building Research Shanghai Branch, Shanghai and other places

Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists

Directing the Metabolism of Drugs Away from CYP450: The Use of Oxetane Rings

PDF) CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis

Feng Ren LinkedIn